PF-06842874
PF-06842874 is a CDK4/Cyclin D1 and CDK6/Cyclin D3 inhibitor (Ki values are 62 and 130 nM, respectively) . PF-06842874 can be used in the research of pulmonary arterial hypertension and cancer[1].
Product Specifications
CAS Number
2516247-98-4
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer; Cardiovascular Disease
Smiles
O=C1N(C2CCCC2)C3=CC(N[C@H]4[C@@H](COCC4)O)=NC=C3C(C)=C1C(C)=O
Molecular Formula
C21H27N3O4
Molecular Weight
385.46
References & Citations
[1]Samit Kumar BhattacharyaI, et al. Anti-proliferative agents for treating pah. WO2020212865A1. Pfizer Inc. 2020-04-15.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK4; CDK6
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682837-100 1x 100 µL
Desmoglein-3 (Squamous Cell Marker) (DSG3/2837), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680718-500 1x 500 µL
HER-2 / CD340 (HRB2/718), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941952-500 1x 500 µL
CD21 (Mature B-Cell & Follicular Dendritic Cell Marker) (CR2/1952), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details